Related Experiment Video
Updated: Jul 26, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Atrial fibrillation after coronary bypass: etiology and pharmacologic prevention
V K S Jayam1, G C Flaker, J W Jones
1Division of Cardiology, University of Missouri-Columbia, Columbia, MO 65201, USA.
Insights
Atrial Fibrillation (AF) is a common complication after coronary bypass surgery. This review examines pharmacologic strategies to prevent post-bypass AF, a persistent challenge for cardiac care teams.
Area of Science:
- Cardiology
- Cardiac Surgery
- Pharmacology
Background:
- Coronary bypass surgery is a common procedure in the US, with over 400,000 patients annually.
- Atrial Fibrillation (AF) is the most frequent complication post-coronary bypass surgery.
- Post-bypass AF presents significant physiological challenges and impacts healthcare resource utilization.
Purpose of the Study:
- To review the existing literature on post-coronary bypass surgery Atrial Fibrillation.
- To emphasize pharmacologic interventions for the prevention of post-bypass AF.
- To explore the unique features of AF occurrence related to perioperative circumstances.
Main Methods:
- Systematic review of published literature on post-coronary bypass surgery AF.
- Analysis of clinical observations regarding perioperative factors influencing AF.
- Evaluation of pharmacologic and non-pharmacologic therapies for AF prevention.
Main Results:
- Atrial Fibrillation remains a significant and persistent complication after coronary bypass surgery.
- Numerous therapies have been investigated for AF prevention, with varying degrees of success.
- The occurrence of post-bypass AF exhibits unique characteristics tied to the perioperative period.
Conclusions:
- Pharmacologic prevention strategies for post-bypass AF require further investigation and optimization.
- Understanding perioperative influences is crucial for mitigating AF risk.
- Continued research is needed to address this tenacious clinical problem.
Abstract:
Coronary bypass surgery is performed on over 400,000 patients each year in the United States. Atrial Fibrillation (AF) is the most common complication after bypass surgery. The significance of its occurrence lies not only in the potentially dangerous and physiologic derangement to patients, but also in the impact it has on the utilization of health care resources. Several clinical observations suggest that the occurrence of atrial fibrillation after bypass surgery has some unique features related to the perioperative circumstances. Numerous therapies, both pharmacologic and non-pharmacologic have been tested to prevent this tenacious problem. Its persistence continues to intrigue cardio-thoracic surgeons, cardiologists, anesthesiologists and the insurers alike. In this review we discuss the published literature on postbypass AF, with a special emphasis on pharmacologic prevention.
More Related Videos
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Aortic Regurgitation III: Medical Management
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Dysrhythmias VI: Management of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

